U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Muscle Meds Performance Technologies - 04/19/2015
  1. Warning Letters


Muscle Meds Performance Technologies

Muscle Meds Performance Technologies

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
 Food and Drug Administration
5100 Paint Branch Parkway
College Park, MD 20740


Craig R. Larsen, Esq.
Legal & Regulatory Affairs
MuscleMeds Performance Technologies
163 East Main Street, Suite 324
Little Falls, NJ 07424

Dear Mr. Larsen:

The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter dated April 24, 2012. Based on our review, it appears that you have addressed the violations contained in this Warning Letter. Future FDA assessments and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act (the Act) and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent review of your web sites or through other means.



Latasha A. Robinson
Team Leader
Labeling and Dietary Supplement
            Compliance Team
Center for Food Safety
            and Applied Nutrition